Your 25-second video preview has ended.
to continue watching, please Log In or Register:
What is Myopic CNV?
Kyoko Ohno-Matsui, MD, PhD, of the Tokyo Medical and Dental University, Japan, provides an updated definition of myopic CNV, outlines the current understanding of the epidemiology and natural history of the condition, and discusses why the review paper’s recommendations are important for physicians.
This publication, entitled “Myopic choroidal neovascularisation: current concepts and update on clinical management”, is available here.
(0:11) Why is the treatment guidance review paper important for physicians treating myopic CNV?
(1:27) What is the definition of myopic CNV?
(2:45) How common and serious is myopic CNV?
(4:29) What is the difference between nAMD and myopic CNV? Why is it important to understand the difference?
This video is intended for physicians outside of the U.S.
3,029 video views since 1/21/2015. 6,007 total series views.
Novartis Pharma AG
CH-4002 Basel, Switzerland ©2014 Novartis Pharma AG Dec 2014 GLRET/LUC/0274